structured testing and treatment for obstructive sleep apnea in patients with atrial fibrillation

Conditions: Atrial Fibrillation; Obstructive Sleep Apnea

Summary: the main goal of this prospective pre-post implementation study is to investigate how a structured testing and treatment program for obstructive sleep apnea using the nox t3s device and a fitbit smartwatch with the fibricheck algorithm impacts the proportion of atrial fibrillation (af) in an af population. participants will wear the nox t3s respiratory polygraphy device for one night at home. in case of a positive obstructive sleep apnea diagnosis, patients will be referred to the sleep clinic for a polysomnography examination. patients positively diagnosed with polygraph will be monitored semi-continuously with the fitbit smartwatch for three months. after the polysomnography examination, the positively diagnosed patients will be monitored semi-continuously for another three months after initiation of treatment (mostly continuous positive airway pressure (cpap) treatment). additionally, patients will be administered satisfaction and symptom burden questionnaires twice: right after the polysomnography examination and after the 3-month treatment.

atrial fibrillation (af) is the most prevalent arrhythmia globally. research has shown that af is associated with various risk factors such as hypertension, diabetes, obesity, and obstructive sleep apnea. obstructive sleep apnea is a sleep-disordered breathing condition that is highly prevalent in af patients, contributing to the development and progression of af. despite the high prevalence of obstructive sleep apnea in af patients (about 62%), it often goes underrecognized and underdiagnosed. lack of symptom reporting and easily accessible screening tools and strategies contribute to this underdiagnosis. the standard diagnostic method is through polysomnography, which, while effective, has drawbacks such as high costs, labor intensity, and time-consuming nature, making it challenging to use as a screening tool. (cardio)respiratory polygraphy devices, such as the nox-t3s, are gaining interest for obstructive sleep apnea detection due to their user-friendly nature, comfort, convenience, and home useability. a previous validation study showed that the nox-t3s polygraphy device had high accuracy, sensitivity, and specificity and was also the most user-friendly for obstructive sleep apnea detection in af patients. besides the screening, retrospective research has shown that obstructive sleep apnea treatment with the gold standard method, continuous positive airway pressure (cpap), positively influences af recurrence through improved antiarrhythmic therapy. current literature suggests early obstructive sleep apnea diagnosis, followed by early cpap treatment, could reduce af recurrence. however, prospective studies supporting this are lacking. therefore, additional information on the heart rhythm of af patients, monitored in a (semi)-continuous manner before and after treatment initiation, would be valuable to investigate if treatment (mostly cpap) leads to a reduction in af events. however, implementing a care pathway using the nox t3s for structured obstructive sleep apnea testing and the fitbit versa smartwatch with the fibricheck algorithm for the follow-up of af recurrence in standard clinical care in an af population still needs to be evaluated.

Eligibility criteria:
inclusion criteria: * patients in whom af (paroxysmal or persistent) is diagnosed with a 12-lead ecg * patients who experience symptoms of their af (mehra ≥ 2a) * older than 18 years * owning a smartphone compatible with fitbit and fibricheck applications (i.e. recent versions of apple ios or android drivers) * ability to sign the informed consent exclusion criteria: * patients diagnosed with permanent af or only atrial flutter * prior/recent polysomnography evaluation * prior/active cpap/bipap/asv treatment * cognitive impairment * inability to speak or fully understand dutch * pacemaker-dependent heart rhythm

Keywords: atrial fibrillation obstructive sleep apnea cardiorespiratory polygraphy continuous positive airway pressure mobile health technology